ThermoGenesis Holdings (formerly known as Cesca Therapeutics) is a regenerative medicine company that develops, commercializes and markets a range of automated technologies for cell-based therapeutics. Its device division provides a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology. ThermoGenesis’s clinical development division is leveraging its proprietary AutoXpress technology platform to develop stem cell-based therapies in the immuno-oncology, vascular, cardiology and orthopedic markets.
Type | Public | |
Founded | 1986 | |
HQ | Rancho Cordova, CA, US | Map |
Website | thermogenesis.com | |
Employee Ratings | More |
USD | |
---|---|
Revenue (Q2, 2020) | 2.2m |
Gross profit (Q2, 2020) | (2.6m) |
Gross profit margin (Q2, 2020), % | (117.4%) |
Net income (Q2, 2020) | (6.5m) |
EBIT (Q2, 2020) | (5.2m) |
Market capitalization (15-Jan-2021) | 18.1m |
Closing stock price (15-Jan-2021) | 2.3 |
Cash (30-Jun-2020) | 7.0m |
EV | 12.4m |
USD | Q1, 2012 | Q2, 2012 | Q3, 2012 | Q1, 2013 | Q2, 2013 | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 4.9m | 4.8m | 4.9m | 4.1m | 4.8m | 4.9m | 3.6m | 4.5m | 4.0m | 3.7m | 4.6m | 4.0m | 2.8m | 3.3m | 2.8m | 3.8m | 4.0m | 3.3m | 3.1m | 1.9m | 2.0m | 3.1m | 3.0m | 4.3m | 4.1m | 3.2m | 2.2m |
Cost of goods sold | 2.9m | 3.1m | 3.7m | 2.5m | 2.8m | 3.2m | 2.3m | 2.7m | 2.5m | 2.5m | 3.1m | 2.9m | 2.5m | 2.3m | 2.4m | 2.4m | 2.5m | 1.9m | 9.9m | 1.5m | 1.6m | 2.5m | 1.7m | 2.4m | 2.2m | 1.7m | 4.9m |
Gross profit | 2.0m | 1.7m | 1.2m | 1.6m | 2.0m | 1.7m | 1.4m | 1.8m | 1.5m | 1.2m | 1.5m | 1.1m | 367.0k | 1.0m | 408.0k | 1.4m | 1.6m | 1.4m | (6.8m) | 352.0k | 363.0k | 655.0k | 1.3m | 2.0m | 1.9m | 1.5m | (2.6m) |
Gross profit Margin, % | 41% | 36% | 24% | 39% | 41% | 34% | 38% | 40% | 38% | 32% | 33% | 28% | 13% | 31% | 14% | 37% | 39% | 42% | (221%) | 19% | 18% | 21% | 42% | 45% | 47% | 47% | (117%) |
USD | Q1, 2012 | Q2, 2012 | Q3, 2012 | Q1, 2013 | Q2, 2013 | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 10.8m | 8.7m | 8.5m | 8.8m | 7.5m | 7.5m | 5.3m | 2.3m | 6.6m | 10.7m | 8.4m | 4.8m | 6.6m | 2.9m | 7.2m | 5.6m | 4.9m | 3.8m | 2.5m | 2.9m | 3.1m | 2.2m | 2.2m | 2.4m | 2.8m | 5.7m | 7.0m |
Accounts Receivable | 4.4m | 5.0m | 4.8m | 3.5m | 5.4m | 4.9m | 4.2m | 5.5m | 5.6m | 4.4m | 4.6m | 5.7m | 3.6m | 3.5m | 4.0m | 3.0m | 3.0m | 3.0m | 258.0k | 1.5m | 2.1m | 2.0m | 3.1m | 4.5m | 2.0m | 1.7m | |
Prepaid Expenses | 315.0k | 170.0k | 111.0k | 366.0k | 420.0k | 338.0k | 319.0k | 136.0k | 198.0k | 490.0k | 300.0k | 200.0k | 131.0k | 336.0k | 262.0k | 203.0k | 260.0k | 334.0k | 557.0k | 286.0k | 313.0k | 389.0k | 451.0k | 429.0k | 837.0k | ||
Inventories | 6.6m | 6.8m | 6.4m | 6.2m | 5.4m | 4.3m | 4.4m | 4.2m | 4.8m | 5.9m | 5.2m | 5.0m | 4.0m | 4.0m | 3.5m | 3.4m | 2.8m | 3.5m | 282.0k | 5.2m | 4.3m | 4.3m | 4.0m | 3.4m | 4.2m | 5.2m |
USD | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
---|---|---|---|---|---|---|---|---|
Net Income | (5.0m) | (3.1m) | (8.6m) | (14.9m) | (18.6m) | (2.8m) | (40.9m) | (10.1m) |
Depreciation and Amortization | 604.0k | 538.0k | 993.0k | 1.4m | 1.2m | 322.0k | 670.0k | 805.0k |
Inventories | 120.0k | 795.0k | (1.3m) | 416.0k | 375.0k | (367.0k) | 61.0k | 610.0k |
Accounts Payable | 696.0k | 619.0k | (295.0k) | 1.4m | (2.4m) | 469.0k | 214.0k | (966.0k) |
USD | Q1, 2012 | Q2, 2012 | Q3, 2012 | Q1, 2013 | Q2, 2013 | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | (1.2m) | (2.5m) | (4.2m) | 995.0k | 432.0k | (689.0k) | (2.3m) | (3.9m) | (5.8m) | (3.3m) | (7.7m) | (12.5m) | (3.4m) | (4.0m) | (14.9m) | (22.4m) | (25.8m) | (27.9m) | (3.4m) | (30.5m) | (33.6m) | (2.0m) | (3.5m) | (5.9m) | (4.7m) | (11.3m) |
Depreciation and Amortization | 99.0k | 202.0k | 388.0k | 134.0k | 266.0k | 400.0k | 156.0k | 327.0k | 587.0k | 322.0k | 667.0k | 1.0m | 365.0k | 659.0k | 876.0k | 261.0k | 473.0k | 660.0k | 159.0k | 333.0k | 506.0k | 212.0k | 402.0k | 604.0k | 199.0k | 392.0k |
Inventories | 230.0k | (322.0k) | 20.0k | 13.0k | 710.0k | 994.0k | (162.0k) | 7.0k | (430.0k) | (332.0k) | 157.0k | 66.0k | 594.0k | 568.0k | 568.0k | 258.0k | 811.0k | 599.0k | (224.0k) | (358.0k) | 336.0k | 99.0k | 449.0k | 980.0k | (400.0k) | (5.1m) |
Accounts Payable | 29.0k | (143.0k) | 131.0k | (982.0k) | (1.1m) | (1.1m) | 112.0k | (369.0k) | (397.0k) | (571.0k) | (404.0k) | 1.1m | 300.0k | (626.0k) | (1.7m) | (832.0k) | (587.0k) | (738.0k) | 69.0k | (242.0k) | (407.0k) | 38.0k | 749.0k | (542.0k) | 1.0m | 1.8m |
USD | Q1, 2012 |
---|---|
Financial Leverage | 1.2 x |
ThermoGenesis has 600 Twitter Followers. The number of followers has increased 1.9% month over month and increased 3.1% quarter over quarter
134
Tweets
2.4k
Following
600
Followers
14
Tweets last 30 days
0.4
Avg. likes per Tweet
35.7%
Tweets with engagement
When was ThermoGenesis founded?
ThermoGenesis was founded in 1986.
Who are ThermoGenesis key executives?
ThermoGenesis's key executives are Chris Xu, Philip Coelho and Debra Donaghy.
How many employees does ThermoGenesis have?
ThermoGenesis has 53 employees.
What is ThermoGenesis revenue?
Latest ThermoGenesis annual revenue is $13 m.
What is ThermoGenesis revenue per employee?
Latest ThermoGenesis revenue per employee is $246.2 k.
Who are ThermoGenesis competitors?
Competitors of ThermoGenesis include Neuronasal, Balmes Transplantation and Rigvir.
Where is ThermoGenesis headquarters?
ThermoGenesis headquarters is located at 2711 Citrus Rd, Rancho Cordova.
Where are ThermoGenesis offices?
ThermoGenesis has offices in Rancho Cordova and Wuxi Shi.
How many offices does ThermoGenesis have?
ThermoGenesis has 2 offices.
Receive alerts for 300+ data fields across thousands of companies